Other

2028

Abbott 2028 decreased by 75.9% to $700.00M in Q4 2025 compared to the prior quarter. Over 3 years (FY 2022 to FY 2025), 2028 shows a downward trend with a -14.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ2 2025
Last reportedQ1 2026

How to read this metric

A predictable and manageable maturity schedule indicates strong financial planning and lower risk of default.

Detailed definition

This represents the specific portion of long-term debt principal scheduled for repayment during the 2028 fiscal year. It...

Peer comparison

Most large-cap industrial companies maintain a balanced maturity schedule to avoid concentrated repayment pressure.

Metric ID: other_long_term_debt_maturities_repayments_of_principal__62d406

Historical Data

4 periods
 Q4 '22Q4 '23Q4 '24Q4 '25
Value$1.10B$1.50B$2.90B$700.00M
QoQ Change+36.4%+93.3%-75.9%
YoY Change+36.4%+93.3%-75.9%
Range$700.00M$2.90B
Avg YoY Growth+17.9%
Median YoY Growth+36.4%

Frequently Asked Questions

What is Abbott's 2028?
Abbott (ABT) reported 2028 of $700.00M in Q4 2025.
What is the long-term trend for Abbott's 2028?
Over 3 years (2022 to 2025), Abbott's 2028 has grown at a -14.0% compound annual growth rate (CAGR), from $1.10B to $700.00M.
What does 2028 mean?
The amount of long-term debt principal that must be repaid in 2028.